Systematic review summarizes the role of interleukin-6 in multiple sclerosis, indicating its importance in inflammation.
To summarize the current evidence on the clinical significance of interleukin (IL)-6 in multiple sclerosis (MS).
No takes yet. Share an insight, caveat, or question.
Seminario et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: